menu
Patient Recruitment and Retention Services Market is estimated to be worth USD 5.3 billion in 2030
Patient Recruitment and Retention Services Market is estimated to be worth USD 5.3 billion in 2030
A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers

RootsAnalysis  is pleased to announce thepublication of its recent study, titled, “Patient Recruitment and RetentionServices Market,2019-2030.”

Thereport offers a comprehensive study of the current scenario and futurepotential of the players providing patient enrollment and retention services.The study features an in-depth analysis, highlighting the capabilities of thevarious stakeholders in this domain. In addition to other elements, the studyincludes:

·       A detailed assessment of the current marketlandscape of companies offering patient recruitment and retention services.

·       An analysis of the most active regions (interms of patient recruitment activity) engaged in this domain, featuringschematic world map representations that highlight key hubs across the globe.

·       An insightful 2X2 representation of theresults of a competitiveness analysis of various service providers highlightingcapable players in this domain, based on their respective capabilities.

·       Comprehensive profiles of patient recruitmentand retention service providers (shortlisted on the basis of the number ofservices).

·       An analysis of the partnerships that havebeen established in this domain, in the recent past

·       A review of emerging trends in the industryto overcome the challenges associated with patient recruitment and retention

Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)

TherapeuticArea

·       Oncology

·       Infectious Diseases

·       Cardiovascular Diseases

·       CNS Disorders

·       Respiratory Disorders

·       Metabolic Disorders

·       Others

Stepsin Patient Recruitment Process

·       Pre-screening

·       Screening

Phaseof Development

·       Phase I

·       Phase II

·       Phase III

·       Phase IV

KeyGeographical Region

·       North America

·       Europe

·       Asia-Pacific

·       Rest of the world

Requestfor PDF Sample: https://www.rootsanalysis.com/reports/245/request-sample.html

Transcriptsof interviews held with the following senior level representatives ofstakeholder companies

·       Simon Klaasen, Co-founder and ManagingDirector, Link2Trials

·       Hagit Nof, Chief Operation Officer andBusiness Development Officer, nRollmed

·       Paul Ivsin, Managing Director, Seeker Health

Keycompanies covered in the report

·       Acurian        

·       BBK Worldwide

·       Bright Pharmaceuticals Services

·       ClinEdge

·       CSSi

·       CTM

·       FIDELIS RESEARCH

·       Ignite Data

·       Integrated Clinical Trial Services

·       MMG

·       Pacific Groove

·       Polaris BioPharma Consulting

·       Topstone Research

·       TrialWire

·       Tudor Reilly Health

·       WCCT Global

GetCustomized Report:

https://www.rootsanalysis.com/reports/245/request-customization.html    

AboutRoots Analysis

RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

ContactInformation

RootsAnalysis Private Limited

GauravChaudhary

+1(415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

 

AlsoRead our Latest Publication

BiopharmaceuticalContract Manufacturing Market

ImmunocytokinesMarket

ViralVectors, Non-Viral Vectors and Gene Therapy Manufacturing Market

mRNATherapeutics and Vaccines Market, 2020-2030

T-Cell(CAR-T, TCR, and TIL) Therapies Market